OncoMed Pharmaceuticals, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (40)

Latest Posts

About This Stock More About This Stock
Morning Call For Thursday, Oct. 18
Article By: Jim Van Meerten
Thursday, October 18, 2018 7:58 AM EDT
Dec E-mini S&Ps (ESZ18 -0.39%) this morning are down -0.38% and the 10-year T-note yield climbed to a 1-week high of 3.21% on signs the Fed will continue to raise interest rates into next year.
In this article: AA, FLR, GPS, PTI, SEE, STZ, KALU, CHRW, TCBI, OMED, ACRS, ZG, FSCT, KRYS
Read
Biotech Stock Roundup: Geron Gains On Interim Data, OncoMed Slumps On Pipeline Setback
Article By: Arpita Dutt
Wednesday, April 12, 2017 10:13 AM EDT
Several companies including Geron and OncoMed provided key pipeline updates this week. While Geron’s shares were up this week, OncoMed’s shares plunged and hit a 52-week low.
In this article: GERN, INCY, REGN, CELG, GILD, VRTX, OMED
Read
Bristol-Myers Falls As Merck Upstages With New Lung Cancer Data
Article By: The Fly
Monday, October 10, 2016 6:35 PM EDT
Merck and Bristol-Myers are in focus Monday after the biopharmaceutical giants reported divergent success rates for their respective lung cancer therapies at this weekend's meeting of the European Society for Medical Oncology.
In this article: BMY, MRK Also: NVS, BIIB, OMED, TSRO, AVXS
Read
Overweight These 3 Safe And Growing Blue Chip Stocks
Article By: Bret Jensen
Saturday, April 30, 2016 10:15 AM EDT
Operating in a sector unaffected by the global economic slowdown, these three safe stocks are the best buys out of the small group of stocks able to grow.
In this article: AMGN, CELG, ABBV Also: ABT, AGN, BMY, IBM, PFE, STJ, MDVN, AAPL, INTC, MSFT, OMED
Read

Latest Tweets for $OMED

No tweets yet!

PARTNER HEADLINES